Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial Carcinoma

NCT04491643 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT04491643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04491643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial Carcinoma
Lead sponsor
Fudan University
Phase
Phase 2
Overall status
Completed
Start date
September 1, 2020
Completion date
April 11, 2025
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial carcinoma stage i